{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T03:17:33Z","timestamp":1782530253484,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.humpath.2024.07.003","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T17:33:59Z","timestamp":1720114439000},"page":"105626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Clinicopathologic features and outcomes of acute leukemia harboring PICALM::MLLT10 fusion"],"prefix":"10.1016","volume":"151","author":[{"given":"Jeffrey","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Buglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Herrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Horna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragan","family":"Jevremovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7835-6662","authenticated-orcid":false,"given":"Ji","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2024.07.003_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/leu.2017.213","article-title":"The MLL recombinome of acute leukemias in 2017","volume":"32","author":"Meyer","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2024.07.003_bib2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.molonc.2012.06.004","article-title":"Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution","volume":"6","author":"Cerveira","year":"2012","journal-title":"Mol Oncol"},{"key":"10.1016\/j.humpath.2024.07.003_bib3","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2009-04-215152","article-title":"Novel prognostic subgroups in childhood 11q23\/MLL-rearranged acute myeloid leukemia: results of an international retrospective study","volume":"114","author":"Balgobind","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.07.003_bib4","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/sj.leu.2405074","article-title":"The role of CALM-AF10 gene fusion in acute leukemia","volume":"22","author":"Caudell","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2024.07.003_bib5","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1038\/sj.onc.1210945","article-title":"The leukemogenic CALM\/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros","volume":"27","author":"Greif","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2024.07.003_bib6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.molonc.2008.08.001","article-title":"The CALM and CALM\/AF10 interactor CATS is a marker for proliferation","volume":"2","author":"Archangelo","year":"2008","journal-title":"Mol Oncol"},{"key":"10.1016\/j.humpath.2024.07.003_bib7","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1158\/0008-5472.CAN-06-3749","article-title":"Expression of a CALM-AF10 fusion gene leads to Hoxa cluster overexpression and acute leukemia in transgenic mice","volume":"67","author":"Caudell","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2024.07.003_bib8","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1182\/blood-2012-06-435792","article-title":"A CALM-derived nuclear export signal is essential for CALM-AF10-mediated leukemogenesis","volume":"121","author":"Conway","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.07.003_bib9","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1182\/blood-2009-04-216606","article-title":"Leukemogenic transformation by HOXA cluster genes","volume":"115","author":"Bach","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.07.003_bib10","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/ncb1464","article-title":"Leukaemic transformation by CALM-AF10 involves upregulation of Hoxa5 by hDOT1L","volume":"8","author":"Okada","year":"2006","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.humpath.2024.07.003_bib11","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1182\/blood-2002-09-2913","article-title":"CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage","volume":"102","author":"Asnafi","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.07.003_bib12","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.leukres.2012.07.008","article-title":"PICALM-MLLT10 acute myeloid leukemia: a French cohort of 18 patients","volume":"36","author":"Borel","year":"2012","journal-title":"Leuk Res"},{"key":"10.1016\/j.humpath.2024.07.003_bib13","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.3324\/haematol.2013.086082","article-title":"The prognosis of CALM-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrest","volume":"98","author":"Ben Abdelali","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2024.07.003_bib14","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1038\/leu.2013.149","article-title":"Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia","volume":"27","author":"Lo Nigro","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2024.07.003_bib15","article-title":"WHO classification of Tumours editorial board. Haematolymphoid tumours","author":"Khoury","year":"2022","journal-title":"Lyonia: International Agency for Research on Cancer"},{"key":"10.1016\/j.humpath.2024.07.003_bib16","series-title":"WHO classification of Tumours of Haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.humpath.2024.07.003_bib17","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.07.003_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00428-022-03448-8","article-title":"International Consensus Classification of acute lymphoblastic leukemia\/lymphoma","volume":"482","author":"Duffield","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2024.07.003_bib19","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"Dohner","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.07.003_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/sj.leu.2401614","article-title":"Molecular analysis of the CALM\/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients","volume":"14","author":"Bohlander","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2024.07.003_bib21","first-page":"4662","article-title":"MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): both rearrangements are associated with a poor prognosis","volume":"91","author":"Dreyling","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.07.003_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/(SICI)1098-2264(199905)25:1<33::AID-GCC5>3.0.CO;2-3","article-title":"Mixed-lineage leukemia with t(10;11)(p13;q21): an analysis of AF10-CALM and CALM-AF10 fusion mRNAs and clinical features","volume":"25","author":"Kumon","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2024.07.003_bib23","first-page":"1212","article-title":"The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols","volume":"91","author":"van Grotel","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2024.07.003_bib24","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2024.07.003_bib25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.humpath.2021.05.007","article-title":"CD2 and CD7 are sensitive flow cytometry screening markers for T-lineage acute leukemia(s): a study of 465 acute leukemia cases","volume":"114","author":"Rozenova","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2024.07.003_bib26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/bjh.19067","article-title":"Treatment outcomes of childhood PICALM::MLLT10 acute leukaemias","volume":"204","author":"Mark","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2024.07.003_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000491596","article-title":"Mediastinal myeloid sarcoma with TP53 mutation preceding acute myeloid leukemia with a PICALM-MLLT10 fusion gene","volume":"140","author":"Naesens","year":"2018","journal-title":"Acta Haematol"},{"key":"10.1016\/j.humpath.2024.07.003_bib28","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2120787119","article-title":"Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases","volume":"119","author":"Dai","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2024.07.003_bib29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41375-022-01743-6","article-title":"How T-lymphoblastic leukemia can be classified based on genetics using standard diagnostic techniques enhanced by whole genome sequencing","volume":"37","author":"Muller","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2024.07.003_bib30","first-page":"773","article-title":"14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia","volume":"138","author":"Di Giacomo","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.07.003_bib31","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1158\/2159-8290.CD-21-0145","article-title":"Enhancer hijacking drives oncogenic BCL11B expression in lineage-ambiguous stem cell leukemia","volume":"11","author":"Montefiori","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.humpath.2024.07.003_bib32","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1016\/S1470-2045(19)30031-2","article-title":"Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia","volume":"20","author":"Teachey","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2024.07.003_bib33","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/CCO.0000000000000900","article-title":"Modern treatment approaches to adult acute T-lymphoblastic and myeloid\/T-lymphoblastic leukemia: from current standards to precision medicine","volume":"34","author":"Leoncin","year":"2022","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.humpath.2024.07.003_bib34","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood-2014-10-551895","article-title":"How I treat T-cell acute lymphoblastic leukemia in adults","volume":"126","author":"Litzow","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.07.003_bib35","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1200\/JCO.2016.71.8585","article-title":"Early response-based therapy stratification improves survival in adult early thymic precursor acute lymphoblastic leukemia: a group for research on adult acute lymphoblastic leukemia study","volume":"35","author":"Bond","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2024.07.003_bib36","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/S2352-3026(15)00254-9","article-title":"Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis","volume":"3","author":"Conter","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.humpath.2024.07.003_bib37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2024.07.003_bib38","doi-asserted-by":"crossref","first-page":"e288","DOI":"10.3324\/haematol.2017.185801","article-title":"Prognostic impact of the absence of biallelic deletion at the TRG locus for pediatric patients with T-cell acute lymphoblastic leukemia treated on the Medical Research Council UK Acute Lymphoblastic Leukemia 2003 trial","volume":"103","author":"Farah","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2024.07.003_bib39","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/bjh.15960","article-title":"Early T precursor acute lymphoblastic leukaemia\/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy","volume":"186","author":"Khogeer","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2024.07.003_bib40","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1182\/blood.2023020678","article-title":"Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group study","volume":"142","author":"Wood","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.07.003_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2011.49","article-title":"Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations","volume":"2","author":"Neumann","year":"2012","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.humpath.2024.07.003_bib42","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1080\/10428194.2018.1522442","article-title":"Incidence and survival of T-cell acute lymphoblastic leukemia in the United States","volume":"60","author":"Guru Murthy","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humpath.2024.07.003_bib43","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/bjh.12882","article-title":"Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003","volume":"166","author":"Patrick","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2024.07.003_bib44","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/leu.2012.327","article-title":"Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l","volume":"27","author":"Chen","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2024.07.003_bib45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2141.2011.08986.x","article-title":"EZH2 mutations and their association with PICALM-MLLT10 positive acute leukaemia","volume":"157","author":"Grossmann","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2024.07.003_bib46","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2024.07.003_bib47","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.exphem.2019.04.003","article-title":"Acute myeloid leukemia driven by the CALM-AF10 fusion gene is dependent on BMI1","volume":"74","author":"Barbosa","year":"2019","journal-title":"Exp Hematol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772400128X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772400128X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T08:12:53Z","timestamp":1724141573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004681772400128X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":47,"alternative-id":["S004681772400128X"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2024.07.003","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathologic features and outcomes of acute leukemia harboring PICALM::MLLT10 fusion","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2024.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105626"}}